Who invested in Hemotune?
Hemotune's investors include EISMEA, Venture Kick, Innosuisse, EASME - EU Executive Agency for SMEs and EIT Health, and 1 more on record.

Switzerland · Series B startup
Funding summaryUpdated 26 Oct 2026
$16Mraised across 1 round since 2024, from 1 source
Source recorded
From Hemotune's own website: 2 founders, 4 on the team.
Hemotune's investors include EISMEA, Venture Kick, Innosuisse, EASME - EU Executive Agency for SMEs and EIT Health, and 1 more on record.
Hemotune has raised $16M across 1 round since 2024.
Hemotune's most recent round was a Series B of $16M in Mar 2024.
Its most recent round, $16M in Mar 2024, is also its largest on record.
Hemotune's first round on record, in Mar 2024, was backed by EISMEA, Venture Kick and Innosuisse and 3 others.
Hemotune's latest named round is a Series B, in Mar 2024.
Hemotune is based in Switzerland.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.